Product Information
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $3961.2495 per ML under NDC 00078063941. Its NADAC has been published 467 times since Jul 19, 2017.
Strength
150 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078063941
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
SECUKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125504On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has been published 467 times since Jul 19, 2017, and over the history we have for it it has risen 88.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3961.2495 per ML |
|---|---|
| All-time high | $3976.8992 (Jun 10, 2026) |
| All-time low | $2106.4112 (Jul 19, 2017) |
| 52-week high | $3976.8992 |
| 52-week low | $3682.4025 |
| Median price | $2872.9471 |
| Average price | $3003.6188 |
| Largest weekly change | +9.9% (Jan 23, 2019) |
| Weeks tracked | 467 |
| Tracking since | Jul 19, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
The current National Average Drug Acquisition Cost (NADAC) for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN), manufactured by Novartis Pharmaceuticals Corporation, is $3961.2495 per ML (NDC 00078063941), effective Jun 24, 2026.
How has the price of COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) changed over time?
Over the history we have for it, the NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has risen 88.1%. It has been tracked across 467 weekly CMS publications since Jul 19, 2017.
What are the highest and lowest recorded NADAC prices for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
Since Jul 19, 2017, the NADAC for COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) has ranged from a low of $2106.4112 (Jul 19, 2017) to a high of $3976.8992 (Jun 10, 2026), with a median of $2872.9471 per ML.
Are there cheaper alternatives to COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN), but none are currently priced below it.
Who manufactures COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)?
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) (NDC 00078063941) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification